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Abstract
Background: Protein tyrosine kinases are important enzymes for cell signalling and key targets
for anticancer drug discovery. The catalytic mechanisms of protein tyrosine kinase-catalysed
phosphorylation are not fully understood. Protein tyrosine kinase Csk requires two Mg2+ cations
for activity: one (M1) binds to ATP, and the other (M2) acts as an essential activator.
Results: Experiments in this communication characterize the interaction between M2 and Csk.
Csk activity is sensitive to pH in the range of 6 to 7. Kinetic characterization indicates that the
sensitivity is not due to altered substrate binding, but caused by the sensitivity of M2 binding to pH.
Several residues in the active site with potential of binding M2 are mutated and the effect on metal
activation studied. An active mutant of Asn319 is generated, and this mutation does not alter the
metal binding characteristics. Mutations of Glu236 or Asp332 abolish the kinase activity, precluding
a positive or negative conclusion on their role in M2 coordination. Finally, the ability of divalent
metal cations to activate Csk correlates to a combination of ionic radius and the coordination
number.
Conclusion: These studies demonstrate that M2 binding to Csk is sensitive to pH, which is mainly
responsible for Csk activity change in the acidic arm of the pH response curve. They also
demonstrate critical differences in the metal activator coordination sphere in protein tyrosine
kinase Csk and a protein Ser/Thr kinase, the cAMP-dependent protein kinase. They shed light on
the physical interactions between a protein tyrosine kinase and a divalent metal activator.
Background
Protein tyrosine kinases (PTK)1 are a large family of
enzymes that transfer the γ-phosphate of ATP to tyrosine
hydroxyl groups in proteins. By phosphorylation, PTKs
regulate the conformation and function of their protein
substrates [1]. This covalent modification is a fundamen-
tal mechanism of signal transduction in mammalian cells.
Aberrant activation of many specific protein tyrosine
kinases causes mishaps in cell signalling, and results in
proliferative diseases, such as cancer [2]. Many protein
tyrosine kinases are considered as important targets for
drug development against such diseases [3]. For full
understanding of phosphorylation-mediated signalling
and to provide a knowledge base for anti-PTK drug discov-
ery, it is important to understand the catalytic mecha-
nisms of protein tyrosine kinases.
C-terminal Src kinase (Csk) is a cytoplasmic PTK that
phosphorylates Src family kinases (SFKs) and down-regu-
lates their kinase activities [4,5]. The mechanistic basis of
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catalysis by Csk and PTKs in general is still poorly under-
stood. Csk-catalyzed phosphorylation reaction obeys a
ternary complex mechanism, likely with rapid and ran-
dom binding of ATP-Mg and the phosphate-accepting
substrate [6]. In addition to a Mg2+ cation (M1) as part of
the ATP-Mg complex, Csk requires another Mg2+ ion (M2)
for optimal kinase activity [7,8]. Kinetic studies demon-
strate that M2 is an essential activator [7]. Because the
affinity of Csk for the metal activator at 2.3 mM falls
within the range of the cellular Mg2+ concentration, this
activation may play a regulatory role in the kinase func-
tion [7,9].
Even though Mg2+ is likely the physiological activator, sev-
eral other divalent metal cations can substitute for Mg2+
and activate Csk to various levels [8,10]. For example,
Mn2+ can replace Mg2+ and results in higher activity of Csk,
while Co2+, Ni2+ are not as effective as Mg2+ as an activator.
Zn2+ can also substitute for Mg2+ in binding to the M2
binding site, but it cannot serve as an activator. Thus, Zn2+
acts as an inhibitor of Csk activity competitive against M2
[8]. Another intriguing property of the Csk-metal interac-
tion is that these substitution metals all bind to Csk con-
siderably stronger than the physiological activator, Mg2+.
While Csk binds to Mg2+ with an AC50 of 2.3 mM, the
other metal cations all bind to Csk with AC50 or IC50 in the
low µM range. Among all divalent metal cations tested,
Zn2+ has the highest affinity for Csk, with an IC50 of 0.5
µM [8].
The requirement of two divalent metal cations for full
activity by Csk appears to represent a general catalytic
requirement by all PTKs. Several PTKs from different fam-
ilies, such as v-Fps [11], Yes [12], Src [13], Lck [14], insu-
lin receptor kinase [15] and epidermal growth factor
receptor [16], all require two Mg2+ cations for full activity.
The insulin receptor kinase has been co-crystallized with
both a peptide substrate and an ATP analog [17]. In the
active site, two Mg2+ are observed, providing direct struc-
tural evidence for the presence of two Mg2+ ions in PTK
catalysis. Kinetic analysis reveals that the metal cation
activator might participate in catalysis by different mech-
anisms for different PTKs. For example, M2 activates Csk
and Src by increasing the kcat without affecting the Km for
ATP [7]. However, M2 activates IRK [18] and v-Fps [11] by
decreasing the Km for ATP without affecting the kcat. The
mechanistic basis for such kinetic differences has not been
determined.
Interestingly, a protein Ser/Thr kinase, the cAMP-depend-
ent protein kinase (PKA), also binds to two divalent metal
cations in the active site during catalysis [19]. However,
the second Mg2+ inhibits the kinase activity [20]. Crystal-
lization of PKA complexed with catalytic ligands reveals
that two Mg2+ cations are present in the active site [21].
In the current study, we characterized the parameters for
the interactions between Csk and M2, such as activity sen-
sitivity to pH, required physical parameters of the divalent
metal cation activators, and potential M2 coordinating
residues. Mutagenic studies eliminated a residue as a
potential ligand for M2, but could not determine if two
other residues are involved due to lack of activity in all
mutants varying these residues.
Results
Csk activity is sensitive to pH in the range of 6 to 7
Because many PTKs are molecular targets for drug discov-
ery, it is of high interest to understand the mechanisms of
PTK catalysis. Like most protein tyrosine kinases, the cat-
alytic mechanism of Csk is not fully understood. Csk has
a bell-shaped pH response curve, with a pH optimum of
around 8 (Figure 1). In the acidic arm of the pH curve, the
activity is highly sensitive to pH. At pH 6, the enzyme
shows very little activity, but at pH 7, the enzyme is nearly
fully active. We hypothesize that this sensitivity likely
reflects certain catalytically essential step(s) that is carried
out by a functional group with an apparent pKa in this
range. Elucidation of such catalytically essential step(s)
may shed light on the catalytic mechanism.
To test the above hypothesis, we characterized how steady
state catalytic parameters responded to pH changes in this
range (Figure 2). We first determined the catalytic param-
eters using ATP as the variable substrate. For this purpose,
polyE4Y, a random polymer of Glu and Tyr (4:1), was
used as the phosphate-accepting substrate at a fixed con-
centration of 1 mg ml-1. The apparent Km for ATP
decreased from 200 µM at pH 6 to 91 µM at pH 7.2 (rela-
tive Km from 1 to 0.45 in Figure 2), but the kcat increased
pH optimum of CskFigure 1
pH optimum of Csk. The Csk kinase activity is assayed as 
described in the Methods section. The activity at different pH 
is normalized to that at pH 8.
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approximately 16 fold. The pKa for this kcat change is esti-
mated to be 6.2. This indicates that phosphoryl transfer
but not ATP binding to Csk is sensitive to pH. This pattern
is different from those for PKA, whose apparent Km for
ATP gradually decreases by a factor of 7 when pH
increases from 5.5 to 7 [22]. This contrast in kinetic pat-
terns likely reflects differences in participation by pH-sen-
sitive functional groups in catalysis by these two enzymes.
In PKA, the sensitivity to pH is due to increased binding
of ATP-M1 at a higher pH. Asp184 is a coordination lig-
and for M1 [21]. For Csk, the apparent Km for ATP is also
dependent on the presence of M1, with M1 resulting in
lower Km for ATP [7]. However, because the apparent Km
of Csk for ATP was largely independent of pH, the func-
tion of M1 is likely not affected by pH in this range. The
contrast between Csk and PKA suggests that M1 coordina-
tion in Csk and PKA is different.
Steady state kinetics was then performed using the phos-
phate-accepting substrate as the variable substrate. The
physiological substrates for Csk are the Src family kinases.
Because SFKs are themselves PTKs that autophosphor-
ylate, we used a kinase-defective mutant of Src (kdSrc) as
the substrate. KdSrc contains a point mutation in the
active site (Lys295Met), which abolishes Src kinase activ-
ity but does not affect its ability to serve as a Csk substrate
[23,24]. The Km of Csk for kdSrc did not change signifi-
cantly in response to pH in the range of 6 to 7. However,
the kcat increased over 100-fold (Figure 3A). A similar
kinetic pattern was observed for polyE4Y, a commonly
Effect of pH on Csk catalytic parameters using phosphate-accepting substrate as he vari ble substrateFigure 3
Effect of pH on Csk catalytic parameters using phos-
phate-accepting substrate as the variable substrate. 
(A) KdSrc is used as the variable substrate. (B) PolyE4Y is 
used as the variable substrate.
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Effect of pH on Csk kinetics with ATP as the variable sub-strateFigure 2
Effect of pH on Csk kinetics with ATP as the variable 
substrate. (A) Double reciprocal plot of Csk activity using 
ATP as the variable substrate at pH 6, 6.1 and 6.2. (B) Plots 
of relative kcat and Km for ATP as a function of pH. The phos-
phate-accepting substrate was polyE4Y at 1 mg ml-1. The kcat 
(9.1 min-1) and Km (200 µM) at pH 6 are taken as 1 and all 
other values are relative to those.
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used artificial substrate for PTK activity assays (Figure 3B)
[7,8]. This result indicates that the recognition of the
phosphate-accepting substrate is not affected by pH
changes in this range. Because the kcat may be a function
of both the phosphoryl transfer step and the ADP release
[25], one of these steps is likely affected by pH in this
range.
M2 binding to Csk is sensitive to pH
Because phosphoryl transfer, not substrate binding is sen-
sitive to pH, it is likely that certain functional groups that
catalyze phosphoryl transfer are subject to ionization in
this pH range. Two types of functional groups could fall
within this category. A functional group may directly par-
ticipate in catalysis by interacting with the transition state,
or it may interact with an essential activator. If only one
ionization state of such a group is functional, it would
render Csk phosphoryl transfer sensitive to pH. Because
M2 acts as an essential activator, we determined if M2
binding to Csk was sensitive to pH in this range. The affin-
ity of Csk for M2 can be roughly measured by the AC50,
the concentration of Mg2+ that activates Csk to 50% of its
full activity [7]. For example, at the optimal pH (8.0),
Mg2+ activates Csk with an AC50 of 2.3 mM. We deter-
mined if the AC50 of Csk for Mg2+ activation was sensitive
to pH. As shown in Figure 4A, the ability of Mg2+ to acti-
vate Csk was indeed sensitive to pH. At pH 6.9, the AC50
was 3 mM, close to the optimal AC50. As pH decreased,
progressively higher concentration of Mg2+ was required
for Csk activation. At pH 6.4, 64 mM MgCl2 nearly satu-
rated Csk, and the AC50 was estimated to be 20 mM. At pH
6.3 or below, highest activity was detected at 64 mM, mak-
ing it difficult to estimate an AC50, but it is clear AC50 con-
tinued to increase as pH decreased. It is known that Csk
activity is highly sensitive to ionic inhibition [26], making
it difficult to separate the effect of Mg2+ as an activator
from ionic inhibition at high MgCl2 concentrations.
Despite the lack of an accurate determination of the rela-
tionship between AC50 and pH, it is clear that the AC50 of
Csk for Mg2+ is dependent on pH. The pH dependence of
metal binding is further illustrated by the pH dependence
profile in Figure 4B. The pKa of this function was esti-
mated in the range of 6.2 to 6.5, which correlated to the
pH range where Csk activity was most sensitive to pH.
This result strongly suggests that the sensitivity of phos-
phoryl transfer to pH is at least partly due to sensitivity of
M2 binding to pH. Because the activity is gained with
increased pH, the deprotonated form of the functional
group is responsible for M2 binding.
Characterization of potential metal-coordinating residues 
in the active site of Csk
Only one protein tyrosine kinase, the insulin receptor
kinase, has been co-crystallized with substrate analogs
and divalent metal activators [17]. We compared the
structures of Csk and IRK to identify Csk residues poten-
tially involved in M2 coordination. In IRK, three residues
are involved in metal cation coordination, Asp1150,
Glu1047, and Asn1137. All three residues are conserved
among PTKs, corresponding to Asp332, Glu236 and
Asn319 in Csk [27]. Even though Csk and IRK displayed
some differences in the kinetic patterns of Mg2+ activation,
it is likely that the conserved residues are playing similar
roles in Mg2+ coordination. We performed site-specific
mutagenesis on these residues to determine if they are
involved in metal activator coordination in Csk.
Asn319 is located in the catalytic loop and a universally
conserved residue in all protein kinases, including Ser/Thr
kinases. In IRK, the equivalent residue is involved in coor-
dinating M1. Asn319 was mutated to Asp, His, Gln and
Ser. Only one mutant, Asn319Ser, could be expressed as
an active enzyme. Representative double reciprocal plots
determining catalytic parameters of Asn319Ser mutant are
presented in Figure 5 and summarized in Table 1. Overall,
Mg2+ activation of Csk as a function of pHFi ure 4
Mg2+ activation of Csk as a function of pH. (A) Mg2+ 
activation of Csk is determined at different pH. The pH val-
ues are labeled in the graph. (B) Plot of AC50 as a function of 
pH.
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the catalytic efficiency measured by kcat decreased by a fac-
tor of approximately 10,000, while the apparent Km values
for ATP, polyE4Y and kdSrc did not change significantly
(within a factor of 2). The Mg2+ activation profile of this
mutant was nearly identical to that of wt Csk (Figure 6)
indicating that even though this residue is crucial for Csk
catalysis, it is unlikely to be responsible for the M2 coor-
dination. Because of the large decrease in kcat due to the
Asn319 mutation, there is a possibility that the mutation
may have changed the rate-limiting step in Csk catalysis,
making a direct conclusion about the role of Asn319 in
M2 binding more complicated. The identical Mg2+
responses by Asn319Ser and wild type Csk argue against
this possibility.
Mutation of Glu236 and Asp332 to a number of residues,
Ala, Asp, Gln for Glu236, Ala, Asn, Glu for Asp332, pro-
duced inactive mutants, thus kinetic analysis of their role
in M2 binding is precluded. These two residues remain
likely candidates for coordinating M2, but confirmation
awaits further study by other methods.
Divalent Metal cations of certain size bind to and activate 
Csk
To characterize the physical properties required of the
metal activator, it has been previously determined that
Mn2+, Co2+ and Ni2+ could also serve as activators, while
14 other commercially available divalent metal cations
could not [8,10]. To determine if the ability to activate Csk
correlates to any specific physical attributes, we plotted
the coordination number versus ionic radius [28] and
determined where the activating metal cations were
located on this map (Figure 7). The four divalent metal
cations, Mg2+, Mn2+, Co2+ and Ni2+, that support Csk activ-
ity clustered together with a coordination number of 6
and an ionic radius of 0.65 to 0.8 Angstroms. Two other
metal cations also met these criteria but apparently did
not support the kinase activity: Cr2+ and Fe2+. Both of
these metal ions have multiple valencies, and interfere
with the kinase assay. Fe2+ forms brown precipitates likely
with the enzyme and protein substrate, while Cr2+ forms
precipitates with ATP in the kinase assay. Such interfer-
ences prevent a definitive analysis if they could support
Csk activity. Zn2+ binds to Csk tightly but does not sup-
port Csk activity, thus it inhibits Csk activity as an inhibi-
tor competitive against M2. Zn2+ also falls within the
range of the ionic radius, but has a coordination number
of 4 or 5. This suggests that a coordination number of 6
may be required of the metal cation activator. Although
this analysis suggests that the size and coordination
number are likely important factors in determining if a
metal cation could activate Csk catalysis, other factors
may also be important.
Kinetic analysis of Asn319SerF gure 5
Kinetic analysis of Asn319Ser. Double reciprocal plots of 
Asn319Ser, using ATP (A), kdSrc (B) or polyE4Y (C) as the 
variable substrate. For the determination in (A), polyE4Y is 
used as the phosphate-accepting substrate.
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Discussion
In this communication, we investigated the molecular
basis of a commonly observed catalytic property of Csk.
First, Csk activity is sensitive to pH change in the range of
6 to 7. Steady state kinetics demonstrates that the sensitiv-
ity is not due to the binding of Csk to either ATP-Mg or the
protein substrate. The sensitivity is due to the sensitivity of
M2 binding to pH in this range. Second, several residues
that have the potential for M2 binding were studied by
mutagenesis. These studies eliminated Asn319 in the
active site as a potential ligand for M2 binding, but were
inconclusive about the role of Asp332 and Glu236,
because mutants at these two positions were inactive.
Third, commercially available divalent metal cations were
surveyed for their ability to support Csk activity. A strong
correlation between the ability of divalent metal cation to
support Csk activity and its physical parameters (ionic
radius and the coordination number) was identified.
Divalent metal cations with a coordination number of 6
and an ionic radius of 0.65–0.8 Å were able to support the
activity while ions outside of this range were not. Overall
this investigation provided insights into the kinase-diva-
lent metal interaction in the active site.
The sensitivity of kinase activity to pH has been previously
investigated in the cAMP-dependent protein kinase [22].
Interestingly, the binding of ATP was sensitive to pH for
PKA while the binding of the second Mg2+ to PKA is not
sensitive to pH. This pattern is the opposite of that
observed for Csk, likely reflecting different coordination
patterns for M1 and M2 in Csk and PKA. This is also con-
sistent with the structural information on IRK and PKA.
Although in both PKA and IRK, three conserved residues
(Glu1047, Asn1137, and Asp1150 in IRK, Glu91, Asn171
and Asp184 in PKA) are involved in coordinating M1 and
M2, the positions of M1 and M2 are switched in the two
kinases. In IRK, M1 is coordinated with Asn1127, while
M2 is coordinated with Asp1150 directly and Glu1047
through two water molecules. In PKA, M2 is coordinated
with Asn171, while M1 is coordinated with Asp184.
Because M1 binding to PKA is sensitive to pH, it is likely
due to deprotonation of Asp184. In this case, M2 binding
to IRK would likely be sensitive to pH. This pattern is
observed in Csk. This suggests that Csk and IRK likely uses
a similar M2 binding site. In this case, Glu236 and Asp332
would be expected to be key ligands for M2 coordination.
Our effort to pinpoint the residues for coordinating M2 in
Csk by mutagenic and kinetic studies is not fully success-
ful. We were able to eliminate Asn319 as responsible for
binding to M2, but our results are inconclusive regarding
Asp332 and Glu236 due to the inability to generate active
mutants at these two positions. This highlights the limita-
tion of mutagenic approach to study catalytically essential
residues. Further studies by other tools are required to
solve these issues.
Methods
Generation of Csk mutants
Glutathione S transferase (GST)-Csk fusion proteins were
generated and purified as previously described [29]. Csk
point mutants were generated using QuikChange (Strata-
gene) in the parental plasmid and were confirmed by
DNA sequencing. Kinase-defective Src (kdSrc) was pro-
duced as described previously [23,24].
Enzyme purification
Bacteria harbouring appropriate plasmids were cultured
in LB medium at 37°C with shaking at 250 rpm over-
night. The overnight culture was then mixed with an equal
volume of fresh LB medium, cooled down to about 20°C.
IPTG (0.2 mM) was added to the culture to induce recom-
binant protein expression at 20°C for 12 hours. The GST
fusion proteins were purified by glutathione affinity chro-
matography as previously described [29]. The purified
enzymes were desalted on a Sephadex G25 column equil-
Activation of wt and Asn319Ser mutant of Csk by Mg2+Figure 6
Activation of wt and Asn319Ser mutant of Csk by 
Mg2+. The maximum activities for both wt and Asn319Ser 
are set as 100%.
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Table 1: Catalytic parameters of Csk and Asn319Ser mutant
Parametera Wt Csk Asn319Ser
kcat-ATP (min-1) 160 ± 10 0.01 ± 0.007
Km-ATP (µM) 140 ± 12 150 ± 25
kcat-polyE4Y (min-1) 82 ± 12 0.01 ± 0.001
Km-polyE4Y (µg ml-1) 156 ± 30 220 ± 48
kcat-kdSrc (min-1) 109 ± 3 0.01 ± 0.001
Km-kdSrc (µM) 6.4 ± 0.1 3.4 ± 0.1
aAll assays were performed at least three times. The standard errors 
were calculated from three most consistent assays.
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ibrated with the storage buffer (100 mM Tris-Cl, pH 8.0,
and 0.1% β-mercaptoethanol). Glycerol was added to the
purified fractions to 30% and the enzymes were stored at
-20°C. Protein concentration was determined by the
Bradford assay and the purity of purified proteins was
assessed by SDS-PAGE with coomassie blue staining.
Kinase activity assay
For assaying PTK activity, phosphorylation of polyE4Y and
kdSrc was measured using the acid precipitation assay as
previously described [7]. Standard kinase assay buffer
contains 100 mM EPPS, pH 8, 10% glycerol, 0.1% triton
X-100 and 0.1% β-mercaptoethanol. Reaction time for the
assays was 10 min. Standard assays used polyE4Y at 1 mg
ml-1, or kdSrc at 10 µM as the phosphate-accepting sub-
strate and ATP at 0.2 mM as the phosphate-donating sub-
strate. To determine the kinase activity at different pH, the
kinase buffer contained all the standard buffer compo-
nents except EPPS was replaced by 100 mM MES or Tris at
designated pH. When Km and kcat were determined with
regard to one substrate, the kinase activity was determined
at various concentrations of that substrate in the range of
20 to 200 µg ml-1 for polyE4Y, 1 to 10 µM for kdSrc or 20
to 200 µM for ATP. When the phosphate-accepting sub-
strate (either polyE4Y or kdSrc) was the variable substrate,
ATP concentration was 0.2 mM. PolyE4Y at 1 mg ml-1 was
used when ATP was the variable substrate. The kcat and Km
values were determined by Lineweaver-Burk plots with
linear regression using Microsoft Excel. All steady state
kinetic assays were performed in duplicate, and repeated
at least once. Standard errors were calculated if an assay
was performed at least three times.
Abbreviation used
AC50, the concentration of a divalent metal cation that
activates Csk to 50% of its full activity; Csk, C-terminal Src
kinase; IRK, insulin receptor kinase; PKA, the camp-
dependent protein kinase; PTK, protein tyrosine
kinase(s); SFK, Src family kinase(s).
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